Anthony Prentice - Net Worth and Insider Trading
Anthony Prentice Net Worth
The estimated net worth of Anthony Prentice is at least $14,908 dollars as of 2024-09-27. Anthony Prentice is the Chief Product Officer of GeneDx Holdings Corp and owns about 367 shares of GeneDx Holdings Corp (WGS) stock worth over $14,908. Details can be seen in Anthony Prentice's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony Prentice has not made any transactions after 2022-07-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anthony Prentice
Anthony Prentice Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony Prentice owns 1 companies in total, including GeneDx Holdings Corp (WGS) .
Click here to see the complete history of Anthony Prentice’s form 4 insider trades.
Insider Ownership Summary of Anthony Prentice
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2022-07-26 | Chief Product Officer |
Anthony Prentice Latest Holdings Summary
Anthony Prentice currently owns a total of 1 stock. Anthony Prentice owns 367 shares of GeneDx Holdings Corp (WGS) as of July 26, 2022, with a value of $14,908.
Latest Holdings of Anthony Prentice
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2022-07-26 | 367 | 40.62 | 14,908 |
Holding Weightings of Anthony Prentice
Anthony Prentice Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony Prentice has made a total of 5 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in GeneDx Holdings Corp is the sale of 51 shares on July 26, 2022, which brought Anthony Prentice around $2,496.
Insider Trading History of Anthony Prentice
- 1
Anthony Prentice Trading Performance
Anthony Prentice Ownership Network
Anthony Prentice Owned Company Details
What does GeneDx Holdings Corp do?
Who are the key executives at GeneDx Holdings Corp?
Anthony Prentice is the Chief Product Officer of GeneDx Holdings Corp. Other key executives at GeneDx Holdings Corp include director & Chief Executive Officer Katherine Stueland , Chief Financial Officer Kevin Feeley , and 10 percent owner Opko Health, Inc. .
GeneDx Holdings Corp (WGS) Insider Trades Summary
Over the past 18 months, Anthony Prentice made no insider transaction in GeneDx Holdings Corp (WGS). Other recent insider transactions involving GeneDx Holdings Corp (WGS) include a net sale of 26,624 shares made by Kevin Feeley , a net sale of 18,004 shares made by Kareem Saad , and a net sale of 88,616 shares made by Katherine Stueland .
In summary, during the past 3 months, insiders sold 931,991 shares of GeneDx Holdings Corp (WGS) in total and bought 0 shares, with a net sale of 931,991 shares. During the past 18 months, 1,923,387 shares of GeneDx Holdings Corp (WGS) were sold and 565,642 shares were bought by its insiders, resulting in a net sale of 1,357,745 shares.
GeneDx Holdings Corp (WGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
GeneDx Holdings Corp Insider Transactions
Anthony Prentice Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony Prentice. You might contact Anthony Prentice via mailing address: C/o Sema4 Holdings Corp, 333 Ludlow Street, North Tower, 8th Fl., Stamford Ct 06902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
